transforming care and outcomes with immunotherapy in stage i-iii resectable nsclc
Published 5 months ago • 517 plays • Length 48:02Download video MP4
Download video MP3
Similar videos
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
1:08:00
has immunotherapy brought us to an inflection point in the management of stage i-iii nsclc?
-
52:29
improving outcomes in resectable nsclc: decisions about neoadjuvant and adjuvant immunotherapy
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
59:37
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
1:11:21
maximizing the potential of immunotherapy in unresectable stage iii nsclc
-
59:24
marking new milestones with immunotherapy in locally advanced and early lung cancer
-
39:16
where to next in limited-stage small cell lung cancer? the role of immune checkpoint inhibitors
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
1:06:01
drs. altorki & spicer discuss immunotherapy advances in stage i-iii nsclc: https://bit.ly/3hvzzoz
-
32:52
immunotherapy for early-stage, resectable nsclc: from clinical trial data to guidelines
-
48:44
neoadjuvant, adjuvant, or both: individualized perioperative immunotherapy in resectable nsclc
-
1:06:23
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team
-
1:08:56
toward better outcomes in sclc: immunotherapy has changed the game, but where do we go next?
-
51:59
facilitating progress in the treatment of sclc
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc
-
1:00:53
drs. sepesi & cascone discuss egfr-targeted therapy in early-stage nsclc: https://bit.ly/3ozllfo
-
1:03:14
changing the game for es-sclc with immunotherapy and multidisciplinary collaboration
-
36:55
immunotherapy in lung cancer: rationale, evidence, and implications for the multidisciplinary team